Insights On Pharmaceutical Production
-
Art And Science Of Tech Transfer — Establishing The Path For Success
11/24/2020
Pharmaceutical technology transfer often invokes images of a complicated set of activities required to transfer the development and manufacturing of a product, or products, from one facility to another. This article shares five features of a successful tech transfer, imperatives that we have learned with a focus on drug sponsors working with CDMOs. These imperatives, when applied to project management operations, can deliver extraordinary results.
-
Improve Sterility Assurance And Data Integrity In A 503B Compounding Pharmacy
9/18/2020
Implementing automated technologies and robotics could be the solution 503B compounding pharmacies need to overcome growing issues with sterility and data integrity.
-
Fareva La Vallée
9/23/2019
Fareva La Vallee, 30 Years of experience on a wide range of processes. This video includes commentary from corporate management, chemistry, health safety and the environment, technical, Logistics, production, quality control and regulatory. Hopefully watching this video will give you a good feel of who we are and will create the desire to know us better.
-
Expanding Sterile Crystallization Capabilities To Meet Rising Customer Demand
2/11/2020
Production of sterile powders requires specialized expertise and capabilities in sterile crystallization. Learn what your CDMO capabilities should be in order to deliver a quality product.
-
Optimize Scale-Up And Increase Capacity For Vaccine And Therapeutic Manufacturing
11/18/2020
In order to accelerate development and manufacturing in the era of SARS-CoV-2, companies are designing scale-up processes in parallel with Phase III clinical trials, redefining the risk tolerance for everyone involved. Read this article to consider a new way of doing business by reviewing existing capabilities, assessing risk tolerance, and identifying key resources to accomplish your goals.
-
Nanoform's CESS® Technology
10/20/2020
Christian Jones from Nanoform talks to the DDF Summit in Berlin, Germany, on how the company's award-winning CESS® technology can be used in Nanoforming™ Future Medicines.
-
2,000 L HyPerforma Single-Use Bioreactor Evaluation
5/7/2019
The stirred-tank reactor is the most commonly utilized reactor type in biotechnology. Read more about the Thermo Scientific™ HyPerforma™ Single-Use Bioreactor (S.U.B.). It is designed as a stirred-tank reactor for animal cell culture and has the unique advantage of utilizing completely single-use product contact surfaces.
-
How Can Working With An Embedded CMO Benefit Your Drug Product?
8/11/2020
The right CMO can expedite market launch, and an embedded CMO offers many advantages over other CMO models, including access to the extensive capabilities and knowhow of the parent organization.
-
Quantification Of Vector Genomic, Residual DNA In Gene Therapy Vectors
11/10/2020
Bringing cell and gene therapy drugs to market requires improvement in many areas, including analytical testing methods, which are used to determine the safety, strength, and purity of viral vectors.
-
Technical Considerations For Developing Oral Solids (Part 1)
8/3/2020
Navigating your oral solids project from development through commercial manufacture can be a challenging path. In a two-part series, four oral solids experts from Pfizer CentreOne’s global network and partner organizations discuss the technical considerations to be aware of. In this first installment, we look at the importance of technical groundwork and understanding excipients in the early stages of your project.